Literature DB >> 10805476

Angiotensin converting enzyme inhibition in non-diabetic nephropathy with non-nephrotic proteinuria.

M Pennesi, G Torre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10805476

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  4 in total

1.  Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy.

Authors:  Maria Gracia Caletti; Mabel Missoni; Clarisa Vezzani; María Grignoli; Juan Jose Piantanida; Horacio A Repetto; Ramon Exeni; Stella Maris Rasse
Journal:  Pediatr Nephrol       Date:  2011-04-30       Impact factor: 3.714

2.  Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.

Authors:  María Gracia Caletti; Alejandro Balestracci; Mabel Missoni; Clarisa Vezzani
Journal:  Pediatr Nephrol       Date:  2012-12-20       Impact factor: 3.714

3.  ACE-inhibitors-induced metabolic acidosis in a child with nephrotic syndrome.

Authors:  Irene Bruno; Marco Pennesi; Federico Marchetti
Journal:  Pediatr Nephrol       Date:  2003-10-24       Impact factor: 3.714

4.  Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome.

Authors:  Maria Van Dyck; Willem Proesmans
Journal:  Pediatr Nephrol       Date:  2004-04-03       Impact factor: 3.714
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.